0000000000472155

AUTHOR

Petr Hermann

showing 4 related works from this author

Scandium(III) complexes of monophosphorus acid DOTA analogues: a thermodynamic and radiolabelling study with 44 Sc from cyclotron and from a 44 Ti/ 4…

2015

International audience; The complexation ability of DOTA analogs bearing one methylenephosphonic (DO3AP) or methylene-phosphinic (DO3AP PrA and DO3AP ABn) acid pendant arm toward scandium was evaluated. Stability constants of their scandium(III) complexes were determined by potentiometry combined with 45 Sc NMR spectroscopy. The stability constants of the monophosphinate analogues are somewhat lower than that of the Sc–DOTA complex. The phosphorus acid moiety interacts with trivalent scandium even in very acidic solutions forming out-of-cage complexes; the strong affinity of the phosphonate group to Sc(III) precludes stability constant determination of the Sc–DO3AP complex. These results we…

MaleBiodistributionMagnetic Resonance SpectroscopyPhosphorous AcidsInorganic chemistrychemistry.chemical_elementPhosphorus acid[SDV.CAN]Life Sciences [q-bio]/Cancer010402 general chemistryLigands01 natural sciencesInorganic Chemistrychemistry.chemical_compoundHeterocyclic Compounds 1-Ring[SDV.CAN] Life Sciences [q-bio]/CancerOrganometallic CompoundsDOTAAnimalsScandiumPhosphorous acidRats WistarRadioisotopesTitaniumMolecular Structure010405 organic chemistryNuclear magnetic resonance spectroscopyPhosphonate0104 chemical sciencesRatschemistryStability constants of complexesPotentiometryThermodynamicsScandium
researchProduct

A DOTA based bisphosphonate with an albumin binding moiety for delayed body clearance for bone targeting

2016

Radiolabeled bisphosphonates are commonly used in the diagnosis and therapy of bone metastases. Blood clearance of bisphosphonates is usually fast and only 30%-50% of the injected activity is retained in the skeleton, while most of the activity is excreted by the urinary tract. A longer blood circulation may enhance accumulation of bisphosphonate compounds in bone metastases. Therefore, a chemically modified macrocyclic bisphosphonate derivative with an additional human albumin binding entity was synthesized and pharmacokinetics of its complex was evaluated. The DOTA-bisphosphonate conjugate BPAMD was compared against the novel DOTAGA-derived albumin-binding bisphosphonate DOTAGA(428-d-Lys)…

MaleCancer Researchmedicine.medical_specialtymedicine.medical_treatmentSerum albuminGallium RadioisotopesBone and Bones030218 nuclear medicine & medical imagingHeterocyclic Compounds 1-Ring03 medical and health scienceschemistry.chemical_compound0302 clinical medicineIn vivoInternal medicinemedicineAnimalsHumansDOTATissue DistributionRadiology Nuclear Medicine and imagingRats WistarSerum AlbuminDiphosphonatesbiologyAlbuminDiphosphonatesBisphosphonateHuman serum albuminRatsDurapatiteEndocrinologychemistryPositron-Emission Tomography030220 oncology & carcinogenesisbiology.proteinMolecular MedicineAdsorptionEx vivomedicine.drugNuclear Medicine and Biology
researchProduct

68Ga- und 177Lu-markierte Bisphosphonate als Knochenmetastasen-Theranostika

2015

Der erhohte Metabolismus der Knochenmatrix kann zum einen mit der SPECT- und zum anderen mit der PET-Technik visualisiert werden. Als SPECT-Nuklid wird uberwiegend 99 mTc in Form von [99mTc]Bisphosphonat-Komplexen verwendet. Die PET bietet im Gegensatz zur SPECT eine hohere lokale und temporale Auflosung. Mit dem 68Ge/68Ga-Generatorsystem existiert ein mittlerweile bewahrtes PET-Pendant zum etablierten 99mTc-Generator. Neuartige Bisphosphonate (BP) in Kombination mit makrozyklischen Chelatoren sind derzeit weltweit Gegenstand der Forschung. Zur Komplexierung von Ga(III) werden haufig DOTA und NOTA sowie deren Derivate verwendet. Speziell im Fall von DOTA-Derivaten bieten DOTA-BP die Moglich…

GynecologyPhysicsmedicine.medical_specialtyOncologymedicineDer Nuklearmediziner
researchProduct

68Ga-BPAMD: PET-imaging of bone metastases with a generator based positron emitter

2012

Abstract Purpose Bone metastases are a serious aggravation for patients suffering from cancer. Therefore, early recognition of bone metastases is of great interest for further treatment of patients. Bisphosphonates are widely used for scintigraphy of bone lesions with 99m Tc. Using the 68 Ge/ 68 Ga generator together with a macroyclic bisphosphonate a comparable PET-tracer comes into focus. Procedures The bisphosphonate DOTA-conjugated ligand BPAMD was labelled with 68 Ga. [ 68 Ga]BPAMD was evaluated in vitro concerning binding to hydroxyapatite and stability. The tracer's in vivo accumulation was determined on healthy rats and bone metastases bearing animals by μ-PET. Results BPAMD was lab…

MaleCancer Researchmedicine.medical_treatmentBone NeoplasmsElectronsGallium RadioisotopesScintigraphyHeterocyclic Compounds 1-RingIn vivoCell Line TumormedicineAnimalsRadiology Nuclear Medicine and imagingRadiochemistryDiphosphonatesmedicine.diagnostic_testbusiness.industryChemistryPositron emittersCancerPet imagingBisphosphonateLigand (biochemistry)medicine.diseaseRatsDurapatiteBone lesionPositron-Emission TomographyMolecular MedicineNuclear medicinebusinessNuclear Medicine and Biology
researchProduct